India to Netherlands: Carmustine Export Trade Route
India has recorded 20 verified shipments of Carmustine exported to Netherlands, representing a combined trade value of $294.7K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $14.7K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED , which accounts for 88% of total export value with 11 shipments worth $258.7K USD. On the buying side, BROCACEF NL:HUB BROCACEF HEALTHCAR is the largest importer in Netherlands with $126.7K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LTD — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Netherlands Carmustine corridor is one of India's established pharmaceutical export routes, with 20 shipments documented worth a combined $294.7K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED , which alone accounts for roughly 88% of all export value, reflecting the consolidated nature of India's carmustine manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $14.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 30.7%, placing it at rank #11 among India's top carmustine export destinations globally.
On the import side, key buyers of Indian carmustine in Netherlands include BROCACEF NL:HUB BROCACEF HEALTHCAR , BROCACEF NL : DUTCH , Brocacef NL : HUB and 6 others. BROCACEF NL:HUB BROCACEF HEALTHCAR is the single largest importer with 8 shipments valued at $126.7K USD.
